Evidence map›Paper›PMID 35052670›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Multitarget Antioxidant NO-Donor Organic Nitrates: A Novel Approach to Overcome Nitrates Tolerance, an Ex Vivo Study.

Elisabetta Marini, Marta Giorgis, Marta Leporati, Barbara Rolando, Konstantin Chegaev, Loretta Lazzarato, Massimo Bertinaria, Marco Vincenti, Antonella Di Stilo

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Elisabetta MariniDepartment of Drug Science and Technology, University of Turin, via Pietro Giuria 9, I-10125 Torino, Italy.ORCID 0000-0002-3638-5219
Marta GiorgisDepartment of Drug Science and Technology, University of Turin, via Pietro Giuria 9, I-10125 Torino, Italy.ORCID 0000-0002-3282-1220
Marta LeporatiRegional Antidoping & Toxicology Center "Alessandro Bertinaria", Regione Gonzole 10/1, I-10043 Orbassano, Italy.
Barbara RolandoDepartment of Drug Science and Technology, University of Turin, via Pietro Giuria 9, I-10125 Torino, Italy.
Konstantin ChegaevDepartment of Drug Science and Technology, University of Turin, via Pietro Giuria 9, I-10125 Torino, Italy.ORCID 0000-0001-9962-1218
Loretta LazzaratoDepartment of Drug Science and Technology, University of Turin, via Pietro Giuria 9, I-10125 Torino, Italy.ORCID 0000-0001-7100-8593
Massimo BertinariaDepartment of Drug Science and Technology, University of Turin, via Pietro Giuria 9, I-10125 Torino, Italy.ORCID 0000-0002-2533-5830
Marco VincentiDepartment of Chemistry, University of Turin, via Pietro Giuria 5, I-10125 Torino, Italy.ORCID 0000-0002-6275-7194
Antonella Di StiloDepartment of Drug Science and Technology, University of Turin, via Pietro Giuria 9, I-10125 Torino, Italy.
University of Turin · ITRegione Campania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic use of glyceryl trinitrate (GTN) is limited by serious side effects, such as tolerance and endothelial dysfunction of coronary and resistance arteries. Although GTN is used as a drug since more than 130 years, the mechanisms of the vasodilatory effects and of tolerance development to organic nitrates are still incompletely elucidated. New synthesized organic nitrates with and without antioxidant properties were characterized for their ex vivo tolerance profile, in order to investigate the oxidative stress hypothesis of nitrate tolerance. The organic nitrates studied showed different vasodilation and tolerance profiles, probably due to the ability or inability of the compounds to interact with the aldehyde dehydrogenase-2 enzyme (ALDH-2) involved in bioactivation. Furthermore, nitrooxy derivatives endowed with antioxidant properties did not determine the onset of tolerance, even if bioactivated by ALDH-2. The results of this study could be further evidence of the involvement of ALDH-2 in the development of nitrate tolerance. Moreover, the behavior of organic nitrates with antioxidant properties supports the hypothesis of the involvement of ROS in inactivating ALDH-2.

Indexed as

aldehyde dehydrogenase 2antioxidantsmultitarget drugsorganic nitratestolerance

Identifiers

PMID35052670
PMCPMC8773138
OpenAlexW4206010304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.